首页 > 最新文献

International Journal of Noncommunicable Diseases最新文献

英文 中文
Quality of life of diabetes patients in North India: A comparison of different methodologies 印度北部糖尿病患者的生活质量:不同方法的比较
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_13_21
Anuroop Kaur, S. Saini, Gunjeet Kaur, S. Prinja
Background: India is witnessing a dramatic rise in the prevalence of diabetes mellitus. In this study, quality of life (QOL) of patients with diabetes and its determinants were assessed. Second, the valuation of QOL using different methods of measurement was examined. Methods: A community-based survey comprising 306 adults diagnosed with diabetes was undertaken in an urban slum area of Chandigarh city. Direct methods of QOL assessment such as time trade-off (TTO) and Visual Analog Scale (VAS) along with indirect like EuroQol 5-Dimensional 5-Level Instrument (EQ-5D-5L) and the QOL Instrument for Indian Diabetes Patients (QOLID) were used. Multiple linear regression was used to compute coefficients to assess point estimate of QOL using the Indian QOLID tool. Results: Overall, health utility scores for a person with diabetes were 0.68 (with TTO method), 0.60–0.64 (with VAS) analog scale, and EQ-5D-5L method, respectively. Valuation of QOL using direct methods yielded utility values which were significantly higher than indirect methods (EQ-5D-5L). Conclusion: Overall, this study found that diabetes is responsible for physical, psychological, and social role disturbance among the patients. In addition, choice of using direct or indirect methods of utility estimation may have practical implications while calculating incremental cost-effectiveness ratios.
背景:印度正在见证糖尿病患病率的急剧上升。本研究评估糖尿病患者的生活质量(QOL)及其影响因素。其次,采用不同的测量方法评估生活质量。方法:在昌迪加尔市的一个城市贫民窟对306名诊断为糖尿病的成年人进行了一项基于社区的调查。采用时间权衡法(TTO)和视觉模拟量表(VAS)等直接评价方法,以及间接评价方法如EuroQol 5维5级量表(EQ-5D-5L)和印度糖尿病患者生活质量量表(QOLID)。采用多元线性回归计算系数,利用印度QOLID工具评估生活质量的点估计。结果:总体而言,糖尿病患者的健康效用得分分别为0.68 (TTO法)、0.60-0.64 (VAS)模拟量表和EQ-5D-5L法。使用直接方法评估生活质量产生的效用值显著高于间接方法(EQ-5D-5L)。结论:总体而言,本研究发现糖尿病对患者的生理、心理和社会角色障碍负有责任。此外,在计算增量成本效益比时,选择使用直接或间接的效用估计方法可能具有实际意义。
{"title":"Quality of life of diabetes patients in North India: A comparison of different methodologies","authors":"Anuroop Kaur, S. Saini, Gunjeet Kaur, S. Prinja","doi":"10.4103/jncd.jncd_13_21","DOIUrl":"https://doi.org/10.4103/jncd.jncd_13_21","url":null,"abstract":"Background: India is witnessing a dramatic rise in the prevalence of diabetes mellitus. In this study, quality of life (QOL) of patients with diabetes and its determinants were assessed. Second, the valuation of QOL using different methods of measurement was examined. Methods: A community-based survey comprising 306 adults diagnosed with diabetes was undertaken in an urban slum area of Chandigarh city. Direct methods of QOL assessment such as time trade-off (TTO) and Visual Analog Scale (VAS) along with indirect like EuroQol 5-Dimensional 5-Level Instrument (EQ-5D-5L) and the QOL Instrument for Indian Diabetes Patients (QOLID) were used. Multiple linear regression was used to compute coefficients to assess point estimate of QOL using the Indian QOLID tool. Results: Overall, health utility scores for a person with diabetes were 0.68 (with TTO method), 0.60–0.64 (with VAS) analog scale, and EQ-5D-5L method, respectively. Valuation of QOL using direct methods yielded utility values which were significantly higher than indirect methods (EQ-5D-5L). Conclusion: Overall, this study found that diabetes is responsible for physical, psychological, and social role disturbance among the patients. In addition, choice of using direct or indirect methods of utility estimation may have practical implications while calculating incremental cost-effectiveness ratios.","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"7 1","pages":"22 - 29"},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43773849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The readiness of frontline health workers in enhancing diabetes and hypertension self-management education and practice in the community settings in Delhi, India 一线卫生工作者在印度德里社区环境中加强糖尿病和高血压自我管理教育和实践的意愿
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_83_20
S. Basu, S. Garg, S. Hossain, Divya Gupta, Kushagr Duggal
The present study was conducted among accredited social health activists (ASHAs), female frontline health workers of India, to assess their knowledge of self-care management for diabetes mellitus (DM) and hypertension (HTN) and understand their readiness to promote medical adherence. Only 21 (41.2%) participants (n = 51) were aware of all the four major behavioral risk factors, including physical inactivity, unhealthy diet, tobacco smoking, and harmful alcohol use that increased the risk of development and progression of DM and HTN. The ASHAs were positively inclined toward participation in health education activities through home visits but were disinclined to be involved in the home distribution of medications.
本研究在印度认可的社会健康活动家(ASHAs)、女性一线卫生工作者中进行,以评估她们对糖尿病(DM)和高血压(HTN)自我保健管理的知识,并了解她们是否愿意促进医疗依从性。只有21名(41.2%)参与者(n = 51)意识到所有四种主要行为风险因素,包括缺乏运动、不健康饮食、吸烟和有害饮酒,这些因素会增加糖尿病和HTN的发生和进展风险。asha积极倾向于通过家访参与健康教育活动,但不愿意参与家庭药物分发。
{"title":"The readiness of frontline health workers in enhancing diabetes and hypertension self-management education and practice in the community settings in Delhi, India","authors":"S. Basu, S. Garg, S. Hossain, Divya Gupta, Kushagr Duggal","doi":"10.4103/jncd.jncd_83_20","DOIUrl":"https://doi.org/10.4103/jncd.jncd_83_20","url":null,"abstract":"The present study was conducted among accredited social health activists (ASHAs), female frontline health workers of India, to assess their knowledge of self-care management for diabetes mellitus (DM) and hypertension (HTN) and understand their readiness to promote medical adherence. Only 21 (41.2%) participants (n = 51) were aware of all the four major behavioral risk factors, including physical inactivity, unhealthy diet, tobacco smoking, and harmful alcohol use that increased the risk of development and progression of DM and HTN. The ASHAs were positively inclined toward participation in health education activities through home visits but were disinclined to be involved in the home distribution of medications.","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"7 1","pages":"42 - 45"},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43300477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic respiratory disease and coronavirus disease 2019 in developing countries: A systematic review 发展中国家2019年慢性呼吸道疾病和冠状病毒病:系统综述
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_5_22
A. Aggarwal, R. Agarwal, S. Dhooria, K. Prasad, I. Sehgal, V. Muthu
The proportion of coronavirus disease 2019 (COVID-19) patients having a chronic respiratory disease (CRD), and its impact on COVID-19 related patient outcomes, is unclear. We conducted this systematic review to evaluate the proportion of patients with asthma or chronic obstructive pulmonary disease (COPD) among COVID-19 patients, and to assess if comorbid CRD worsens COVID-19 outcomes, in developing countries. We queried PubMed database for studies conducted in developing countries and provided data on the proportion of COVID-19 patients with CRD, or severe disease or mortality among COVID-19 patients with and without CRD. We calculated proportion of CRD patients and relative risk (RR) for each reported outcome of interest. We used random-effects models to summarize our data. We retrieved 1947 citations and included 22 studies from developing countries in our review. The pooled estimate for proportion of asthma and COPD was 2.32% (95% confidence interval [CI] 1.86%–2.83%) and 3.52% (95% CI 2.14%–5.20%), respectively. COVID-19 patients with asthma had a higher risk of severe COVID-19 (summary RR 1.21, 95% CI 1.17–1.25), but not of mortality (summary RR 1.01, 95% CI 0.80–1.28), as compared to COVID-19 patients without asthma. COVID-19 patients with COPD had a higher risk of severe COVID-19 (summary RR 1.48, 95% CI 1.30–1.69) and mortality (summary RR 2.69, 95% CI 1.57–4.61), as compared to COVID-19 patients without COPD. Patients with asthma (but not COPD) in developing countries may be less likely to acquire COVID-19. Both diseases may increase the risk of severe COVID-19, and COPD may increase risk of COVID-19-related mortality.
目前尚不清楚2019冠状病毒病(COVID-19)患者患有慢性呼吸道疾病(CRD)的比例及其对COVID-19相关患者结局的影响。我们进行了这项系统综述,以评估发展中国家的COVID-19患者中哮喘或慢性阻塞性肺疾病(COPD)患者的比例,并评估合并症CRD是否会恶化COVID-19的结局。我们查询了PubMed数据库中在发展中国家进行的研究,并提供了COVID-19患者中发生CRD的比例,或伴有和不伴有CRD的COVID-19患者中严重疾病或死亡率的数据。我们计算了每个报告结果的CRD患者比例和相对风险(RR)。我们使用随机效应模型来总结我们的数据。我们检索了1947条引文,并在我们的综述中纳入了22项来自发展中国家的研究。哮喘和COPD的合并估计比例分别为2.32%(95%可信区间[CI] 1.86%-2.83%)和3.52% (95% CI 2.14%-5.20%)。与没有哮喘的COVID-19患者相比,合并哮喘的COVID-19患者发生严重COVID-19的风险更高(总RR为1.21,95% CI为1.17-1.25),但死亡率不高(总RR为1.01,95% CI为0.80-1.28)。与没有COPD的COVID-19患者相比,合并COPD的COVID-19患者发生严重COVID-19(总RR为1.48,95% CI为1.30-1.69)和死亡率(总RR为2.69,95% CI为1.57-4.61)的风险更高。发展中国家的哮喘(但不包括慢性阻塞性肺病)患者可能不太可能感染COVID-19。这两种疾病都可能增加严重COVID-19的风险,而慢性阻塞性肺病可能增加COVID-19相关死亡的风险。
{"title":"Chronic respiratory disease and coronavirus disease 2019 in developing countries: A systematic review","authors":"A. Aggarwal, R. Agarwal, S. Dhooria, K. Prasad, I. Sehgal, V. Muthu","doi":"10.4103/jncd.jncd_5_22","DOIUrl":"https://doi.org/10.4103/jncd.jncd_5_22","url":null,"abstract":"The proportion of coronavirus disease 2019 (COVID-19) patients having a chronic respiratory disease (CRD), and its impact on COVID-19 related patient outcomes, is unclear. We conducted this systematic review to evaluate the proportion of patients with asthma or chronic obstructive pulmonary disease (COPD) among COVID-19 patients, and to assess if comorbid CRD worsens COVID-19 outcomes, in developing countries. We queried PubMed database for studies conducted in developing countries and provided data on the proportion of COVID-19 patients with CRD, or severe disease or mortality among COVID-19 patients with and without CRD. We calculated proportion of CRD patients and relative risk (RR) for each reported outcome of interest. We used random-effects models to summarize our data. We retrieved 1947 citations and included 22 studies from developing countries in our review. The pooled estimate for proportion of asthma and COPD was 2.32% (95% confidence interval [CI] 1.86%–2.83%) and 3.52% (95% CI 2.14%–5.20%), respectively. COVID-19 patients with asthma had a higher risk of severe COVID-19 (summary RR 1.21, 95% CI 1.17–1.25), but not of mortality (summary RR 1.01, 95% CI 0.80–1.28), as compared to COVID-19 patients without asthma. COVID-19 patients with COPD had a higher risk of severe COVID-19 (summary RR 1.48, 95% CI 1.30–1.69) and mortality (summary RR 2.69, 95% CI 1.57–4.61), as compared to COVID-19 patients without COPD. Patients with asthma (but not COPD) in developing countries may be less likely to acquire COVID-19. Both diseases may increase the risk of severe COVID-19, and COPD may increase risk of COVID-19-related mortality.","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"7 1","pages":"3 - 12"},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45772508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of mental health disorders and synthesis of community-based mental health intervention measures among adolescents after the onset of COVID-19 pandemic time in low middle-income countries: Protocol for systematic review and meta-analysis 中低收入国家COVID-19大流行开始后青少年精神卫生障碍负担和社区精神卫生干预措施的综合:系统评价和荟萃分析方案
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_75_21
I. Saha, Joydeep Majumder, B. Bagepally, S. Ray, A. Saha, Amit Chakrabarti
Adolescents have become victims of the COVID-19 pandemic, leading to the development of several mental health problems. This protocol is aimed to determine the pooled prevalence of mental health disorders among adolescents (10–19 years) during the COVID-19 pandemic time in low middle-income countries (LMIC) and to find different community-based mental health intervention measures in addressing adolescent mental health disorders during COVID-19 pandemic time in LMIC. Articles will be retrieved from databases such as PubMed, EmBase, Scopus, Cochran Central, and Google Scholar using Medical Subject Headings terms, keywords, and text words for each concept. Preprint search servers (MedRx, Cogprints, IndiaRxiv, medRxiv, SSRN) will also be accessed in addition to hand-searching of retrieved articles by forward and backward searching strategies. Data analysis will be conducted as per guidelines provided in the Handbook of Cochrane Systematic Review. RevMan version 5.4 or suitable software will be used for pooled analysis. This proposal is registered in the PROSPERO register (CRD42021278714). Pooled prevalence will depict the overall burden of these neglected health issues. The proposed study would further suffice in identifying evidence-based intervention measures in community settings among adolescents in the background of an ongoing highly infectious disease pandemic.
青少年已成为COVID-19大流行的受害者,导致多种心理健康问题的发展。本方案旨在确定中低收入国家(LMIC)在COVID-19大流行期间青少年(10-19岁)精神健康障碍的总患病率,并寻找不同的社区精神卫生干预措施,以解决中低收入国家(LMIC)在COVID-19大流行期间青少年精神健康障碍问题。文章将从PubMed、EmBase、Scopus、Cochran Central和谷歌Scholar等数据库中检索,使用医学主题标题术语、关键字和每个概念的文本单词。除了通过正向和反向搜索策略对检索文章进行手动搜索外,还将访问预印本搜索服务器(MedRx, Cogprints, IndiaRxiv, medRxiv, SSRN)。数据分析将按照Cochrane系统评价手册提供的指南进行。将使用RevMan版本5.4或合适的软件进行汇总分析。该提案已在PROSPERO寄存器(CRD42021278714)中注册。汇总流行率将描述这些被忽视的健康问题的总体负担。拟议的研究将进一步足以确定在高度传染性疾病持续大流行的背景下,在社区环境中对青少年采取循证干预措施。
{"title":"Burden of mental health disorders and synthesis of community-based mental health intervention measures among adolescents after the onset of COVID-19 pandemic time in low middle-income countries: Protocol for systematic review and meta-analysis","authors":"I. Saha, Joydeep Majumder, B. Bagepally, S. Ray, A. Saha, Amit Chakrabarti","doi":"10.4103/jncd.jncd_75_21","DOIUrl":"https://doi.org/10.4103/jncd.jncd_75_21","url":null,"abstract":"Adolescents have become victims of the COVID-19 pandemic, leading to the development of several mental health problems. This protocol is aimed to determine the pooled prevalence of mental health disorders among adolescents (10–19 years) during the COVID-19 pandemic time in low middle-income countries (LMIC) and to find different community-based mental health intervention measures in addressing adolescent mental health disorders during COVID-19 pandemic time in LMIC. Articles will be retrieved from databases such as PubMed, EmBase, Scopus, Cochran Central, and Google Scholar using Medical Subject Headings terms, keywords, and text words for each concept. Preprint search servers (MedRx, Cogprints, IndiaRxiv, medRxiv, SSRN) will also be accessed in addition to hand-searching of retrieved articles by forward and backward searching strategies. Data analysis will be conducted as per guidelines provided in the Handbook of Cochrane Systematic Review. RevMan version 5.4 or suitable software will be used for pooled analysis. This proposal is registered in the PROSPERO register (CRD42021278714). Pooled prevalence will depict the overall burden of these neglected health issues. The proposed study would further suffice in identifying evidence-based intervention measures in community settings among adolescents in the background of an ongoing highly infectious disease pandemic.","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"7 1","pages":"46 - 51"},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43708746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of physical activity interventions on glycemic control among indigenous African adults – A systematic review protocol 体育活动干预对土著非洲成年人血糖控制的效果——一项系统评价方案
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_37_22
Chythra R Rao, B. Chandrasekaran, N. Ravishankar, E. Rutebemberwa, D. Okello
{"title":"Efficacy of physical activity interventions on glycemic control among indigenous African adults – A systematic review protocol","authors":"Chythra R Rao, B. Chandrasekaran, N. Ravishankar, E. Rutebemberwa, D. Okello","doi":"10.4103/jncd.jncd_37_22","DOIUrl":"https://doi.org/10.4103/jncd.jncd_37_22","url":null,"abstract":"","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70808269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyslipidaemia in Sri Lanka 斯里兰卡的血脂异常
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_14_22
A. Matthias, R. Ekanayake, C. Arambepola
Cardiovascular diseases (CVDs) are the leading cause of mortality in South Asia. Although well-recognized as a major risk factor, dyslipidemia in such populations is not well-reviewed. To review the trends in dyslipidemia, phenotypes, underlying causes, treatment modalities, and management gaps in Sri Lanka. A narrative review was undertaken on published literature on dyslipidemia in Sri Lanka from 2000 to 2020, extracted using PubMed, Google Scholar, and locally published literature. Out of the 33 documents reviewed, only a limited number was available on large-scale population-based studies. High prevalence of metabolic syndrome along with moderately high low-density lipoprotein-cholesterol, low high-density lipoprotein-cholesterol, high triglycerides, and high ApoB and Lp(a) concentrations was seen. Familial hypercholesterolemia was an understudied area with a need for a national screening program. With dyslipidemia guidelines limited to the management of special disease groups, there is a chasm between guidelines and practice at present in Sri Lanka. Unlike in primary prevention, prescribing high-dose statins in secondary prevention of CVD has been satisfactory. Treatment gaps are identified, with room for improvements in lipid screening and achieving lipid goals. Considering the substantial burden identified, education of physicians, optimizing lipid testing, and aggressive treatment of lipids are key initiatives toward optimizing management of dyslipidemia.
心血管疾病是南亚地区死亡的主要原因。尽管人们普遍认为血脂异常是一个主要的危险因素,但这类人群的血脂异常并没有得到很好的评价。回顾斯里兰卡血脂异常的趋势、表型、潜在原因、治疗方式和管理差距。对2000年至2020年斯里兰卡已发表的血脂异常文献进行了叙述性综述,这些文献使用PubMed、谷歌学者和当地发表的文献进行了摘录。在审查的33份文件中,只有有限的数量可用于大规模的基于人群的研究。代谢综合征患病率高,伴有中高低密度脂蛋白胆固醇、低高密度脂蛋白、高甘油三酯以及高ApoB和Lp(a)浓度。家族性高胆固醇血症是一个研究不足的领域,需要进行国家筛查。由于血脂异常指南仅限于特殊疾病群体的管理,斯里兰卡目前的指南和实践之间存在分歧。与一级预防不同,在心血管疾病的二级预防中开大剂量他汀类药物是令人满意的。发现了治疗差距,在脂质筛查和实现脂质目标方面还有改进的空间。考虑到已确定的巨大负担,医生的教育、优化脂质检测和积极治疗脂质是优化血脂异常管理的关键举措。
{"title":"Dyslipidaemia in Sri Lanka","authors":"A. Matthias, R. Ekanayake, C. Arambepola","doi":"10.4103/jncd.jncd_14_22","DOIUrl":"https://doi.org/10.4103/jncd.jncd_14_22","url":null,"abstract":"Cardiovascular diseases (CVDs) are the leading cause of mortality in South Asia. Although well-recognized as a major risk factor, dyslipidemia in such populations is not well-reviewed. To review the trends in dyslipidemia, phenotypes, underlying causes, treatment modalities, and management gaps in Sri Lanka. A narrative review was undertaken on published literature on dyslipidemia in Sri Lanka from 2000 to 2020, extracted using PubMed, Google Scholar, and locally published literature. Out of the 33 documents reviewed, only a limited number was available on large-scale population-based studies. High prevalence of metabolic syndrome along with moderately high low-density lipoprotein-cholesterol, low high-density lipoprotein-cholesterol, high triglycerides, and high ApoB and Lp(a) concentrations was seen. Familial hypercholesterolemia was an understudied area with a need for a national screening program. With dyslipidemia guidelines limited to the management of special disease groups, there is a chasm between guidelines and practice at present in Sri Lanka. Unlike in primary prevention, prescribing high-dose statins in secondary prevention of CVD has been satisfactory. Treatment gaps are identified, with room for improvements in lipid screening and achieving lipid goals. Considering the substantial burden identified, education of physicians, optimizing lipid testing, and aggressive treatment of lipids are key initiatives toward optimizing management of dyslipidemia.","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"7 1","pages":"13 - 21"},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45927587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and implementation of health promoting village model among residents of village of Punjab (India): A study protocol 在旁遮普村居民中发展和实施促进健康的乡村模式(印度):一项研究议定书
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_8_22
Damanpreet Kaur, Kavita, Js Thakur, T. Kiran
{"title":"Development and implementation of health promoting village model among residents of village of Punjab (India): A study protocol","authors":"Damanpreet Kaur, Kavita, Js Thakur, T. Kiran","doi":"10.4103/jncd.jncd_8_22","DOIUrl":"https://doi.org/10.4103/jncd.jncd_8_22","url":null,"abstract":"","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70807829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endocrine disruptors: A rising menace 内分泌干扰物:日益严重的威胁
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_20_22
B. Malhotra, S. Bhadada
{"title":"Endocrine disruptors: A rising menace","authors":"B. Malhotra, S. Bhadada","doi":"10.4103/jncd.jncd_20_22","DOIUrl":"https://doi.org/10.4103/jncd.jncd_20_22","url":null,"abstract":"","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"7 1","pages":"1 - 2"},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47518629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mainstreaming of integrated medicine in health-care delivery system to combat chronic noncommunicable diseases 将综合医学纳入卫生保健提供系统的主流,以防治慢性非传染性疾病
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-01-01 DOI: 10.4103/jncd.jncd_64_22
Js Thakur, R. Paika
{"title":"Mainstreaming of integrated medicine in health-care delivery system to combat chronic noncommunicable diseases","authors":"Js Thakur, R. Paika","doi":"10.4103/jncd.jncd_64_22","DOIUrl":"https://doi.org/10.4103/jncd.jncd_64_22","url":null,"abstract":"","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70808146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spirulina: A daily support to our immune system 螺旋藻:对我们免疫系统的日常支持
IF 0.4 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-11-01 DOI: 10.4103/2468-8827.330650
Subbu Vasudevan, S. Seetharam, Margaret Dohnalek, Elizabeth Cartwright
In recent years, the various health benefits of Cyanobacteria microalgae – such as Arthrospira platensis, commonly called Spirulina, an edible blue-green algae – have attracted scientific attention including micro-level examinations of its bioactive components. As a whole food and nutritional supplement, it serves as a plant protein source, which has shown positive effects across a wide range of human health concerns, from malnutrition to metabolic syndrome. Spirulina bioactives, such as essential amino acids, phycocyanin, polysaccharides, carotenoids, and chlorophyll, and essential vitamins and trace minerals, are responsible for its holistic actions against oxidative stress and inflammation, and its antiviral, antibacterial, and immune-modulating effects. Various in vitro, in vivo, and ex vivo experiments have established Spirulina's mechanism of action and its effect on immunity as a proof of concept. The phenolic compounds and extracellular metabolites released from Spirulina whole food after digestion are postulated to strengthen the epithelial lining with antibacterial effects against pathogenic bacteria, adding to its prebiotic effect on the gut microbiota (like Bifidobacterium and Lactobacillus) due to its fiber content. In this study, the digestibility of Spirulina was assessed by the determination of free amino acids and peptide release during the each phase of digestion in a simulated static digestive model system. The hypothesis bridging poor gut health to low-level inflammation and metabolic syndrome, and the potential to address those issues with nutritional supplementation, such as with Spirulina, could also be beneficial in the long run to reduce comorbid illnesses, such as those associated with the currently prevailing coronavirus disease 2019 pandemic.
近年来,蓝藻微藻的各种健康益处引起了科学界的关注,包括对其生物活性成分的微观检查。作为一种完整的食物和营养补充剂,它是一种植物蛋白来源,在从营养不良到代谢综合征的一系列人类健康问题上都表现出了积极的影响。螺旋藻的生物活性物质,如必需氨基酸、藻蓝蛋白、多糖、类胡萝卜素和叶绿素,以及必需维生素和微量矿物质,负责其对抗氧化应激和炎症的整体作用,以及抗病毒、抗菌和免疫调节作用。各种体外、体内和离体实验已经确立了螺旋藻的作用机制及其对免疫的影响,以此作为概念的证明。螺旋藻全食物消化后释放的酚类化合物和细胞外代谢产物被认为可以增强上皮衬里,对病原菌具有抗菌作用,由于其纤维含量,增加了其对肠道微生物群(如双歧杆菌和乳酸杆菌)的益生元作用。在本研究中,通过在模拟静态消化模型系统中测定消化各阶段的游离氨基酸和肽释放来评估螺旋藻的消化率。从长远来看,将肠道健康状况不佳与低水平炎症和代谢综合征联系起来的假设,以及通过营养补充剂(如螺旋藻)解决这些问题的潜力,也可能有利于减少共病,例如与当前流行的2019冠状病毒病大流行相关的疾病。
{"title":"Spirulina: A daily support to our immune system","authors":"Subbu Vasudevan, S. Seetharam, Margaret Dohnalek, Elizabeth Cartwright","doi":"10.4103/2468-8827.330650","DOIUrl":"https://doi.org/10.4103/2468-8827.330650","url":null,"abstract":"In recent years, the various health benefits of Cyanobacteria microalgae – such as Arthrospira platensis, commonly called Spirulina, an edible blue-green algae – have attracted scientific attention including micro-level examinations of its bioactive components. As a whole food and nutritional supplement, it serves as a plant protein source, which has shown positive effects across a wide range of human health concerns, from malnutrition to metabolic syndrome. Spirulina bioactives, such as essential amino acids, phycocyanin, polysaccharides, carotenoids, and chlorophyll, and essential vitamins and trace minerals, are responsible for its holistic actions against oxidative stress and inflammation, and its antiviral, antibacterial, and immune-modulating effects. Various in vitro, in vivo, and ex vivo experiments have established Spirulina's mechanism of action and its effect on immunity as a proof of concept. The phenolic compounds and extracellular metabolites released from Spirulina whole food after digestion are postulated to strengthen the epithelial lining with antibacterial effects against pathogenic bacteria, adding to its prebiotic effect on the gut microbiota (like Bifidobacterium and Lactobacillus) due to its fiber content. In this study, the digestibility of Spirulina was assessed by the determination of free amino acids and peptide release during the each phase of digestion in a simulated static digestive model system. The hypothesis bridging poor gut health to low-level inflammation and metabolic syndrome, and the potential to address those issues with nutritional supplementation, such as with Spirulina, could also be beneficial in the long run to reduce comorbid illnesses, such as those associated with the currently prevailing coronavirus disease 2019 pandemic.","PeriodicalId":52935,"journal":{"name":"International Journal of Noncommunicable Diseases","volume":"6 1","pages":"47 - 54"},"PeriodicalIF":0.4,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42155955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Noncommunicable Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1